Enhancing SIV-specific immunity in vivo by PD-1 blockade-Reference-Cited by-同舟云学术

Enhancing SIV-specific immunity in vivo by PD-1 blockade

Published:2008-12-10 Issue:7235 Volume:458 Page:206-210
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Velu Vijayakumar,Titanji Kehmia,Zhu Baogong,Husain Sajid,Pladevega Annette,Lai Lilin,Vanderford Thomas H.,Chennareddi Lakshmi,Silvestri Guido,Freeman Gordon J.,Ahmed Rafi,Amara Rama Rao

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature07662.pdf

Reference30 articles.

1. Letvin, N. L. & Walker, B. D. Immunopathogenesis and immunotherapy in AIDS virus infections. Nature Med. 9, 861–866 (2003)

2. Pantaleo, G. & Koup, R. A. Correlates of immune protection in HIV-1 infection: what we know, what we don’t know, what we should know. Nature Med. 10, 806–810 (2004)

3. Moir, S. & Fauci, A. S. Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. J. Allergy Clin. Immunol. 122, 12–19 (2008)

4. Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887–3895 (1992)

5. Sharpe, A. H., Wherry, E. J., Ahmed, R. & Freeman, G. J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nature Immunol. 8, 239–245 (2007)

Cited by 654 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors in infectious disease;Immunological Reviews;2024-09-09

2. Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study;Journal for ImmunoTherapy of Cancer;2024-08

3. PD-1 blockade enhances HIV-1 vaccine-induced CD8⁺ T-cell responses in PWH early ART-treated;2024-07-06

4. Immune restoration by TIGIT blockade is insufficient to control chronic SIV infection;Journal of Virology;2024-06-13

5. Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis;Viruses;2024-05-17